10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,333 | -30.3% | 202 | -5.6% | 0.00% | 0.0% |
| Q2 2023 | $11,950 | +6.0% | 214 | +5.9% | 0.00% | 0.0% |
| Q1 2023 | $11,270 | +67.2% | 202 | +9.2% | 0.00% | 0.0% |
| Q4 2022 | $6,741 | – | 185 | +2212.5% | 0.00% | – |
| Q3 2022 | $0 | – | 8 | -27.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 11 | -68.6% | 0.00% | – |
| Q1 2022 | $3,000 | -72.7% | 35 | -53.3% | 0.00% | -100.0% |
| Q4 2021 | $11,000 | +266.7% | 75 | +275.0% | 0.00% | +100.0% |
| Q3 2021 | $3,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |